Keywords: ranbaxy, 2nd-qtr, sales, rise, 432m, india, laboratories
Ranbaxy's 2nd-qtr 2008 sales rise 13% to $432M
Article | 11 August 2008
India's Ranbaxy Laboratories achieved sales of 18.29 billion rupees ($431.8 million) in the second quarter of 2008, a 12.7% increase year-on-year.
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
